# SCA to acquire BSN medical from EQT VI for EUR 2.74 billion

EQT VI agreed to sell BSN medical, a medical therapy provider in wound care and orthopaedics, to Svenska Cellulosa Aktiebolaget (SCA) in a transaction valuing BSN at EUR 2,740 million. BSN has sales above EUR 860 million and more than 6,000 employees.

- Type: Acquisition
- Announced: 2016-12-19
- Value: $2.88B (2.74B EUR)
- Status: announced
- Products: wound care products, compression therapy products, orthopaedic products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [SCA](https://endata.com/companies/324.md) (acquirer)
- [EQT VI](https://endata.com/companies/598.md) (partner)
- [BSN medical](https://endata.com/companies/599.md) (target)

## Sources

- [prnewswire.co.uk](https://www.prnewswire.co.uk/news-releases/eqt-vi-to-sell-bsn-medical-to-sca-607397626.html), 2016-12-19: "EQT VI Limited ("EQT VI") has entered into an agreement to sell BSN medical Luxembourg Group Holding S.a.r.l. ("BSN medical", "BSN" or the "Company") to Svenska Cellulosa Aktiebolaget ("SCA") in a transaction valuing BSN at EUR 2,740 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.